Oragenics (OGEN) Receivables (2010 - 2016)
Oragenics' (OGEN) quarterly Receivables came in at $32748.0 in Q1 2016, up 10.78% YoY from $29561.0 in Q2 2015, and up 55.09% on a QoQ basis from $21115.0 in Q4 2015.
Oragenics (OGEN) Receivables (2010 - 2016) Analysis & Trends
Oragenics (OGEN) has 7 years of Receivables data on file, last reported at $32748.0 in Q1 2016.
- Quarterly Receivables rose 10.78% year-over-year to $32748.0 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $32748.0 (up 10.78% YoY) and the FY2015 annual result came in at $21115.0, up 35.28% from the prior year.
- Receivables grew to $32748.0 in Q1 2016, from $21115.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $72379.0 in Q3 2012 to a low of $15608.0 in Q4 2014.
- A 5-year average of $41792.9 and a median of $39422.0 in 2012 frame the typical range for Receivables.
- Annual changes were most pronounced in 2012 — Receivables soared 63.27% — and 2014, when it sank 75.78%.
- Tracing OGEN's Receivables over 5 years: stood at $69795.0 in 2012, then retreated by 7.68% to $64434.0 in 2013, then slumped by 75.78% to $15608.0 in 2014, then jumped by 35.28% to $21115.0 in 2015, then jumped by 55.09% to $32748.0 in 2016.
- The last three Receivables figures came in at $32748.0 (Q1 2016), $21115.0 (Q4 2015), and $19367.0 (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 912.74 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 215.33 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.09 Bn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 32,748.00 |
| Dec 31, 2015 | 21,115.00 |
| Sep 30, 2015 | 19,367.00 |
| Jun 30, 2015 | 26,798.00 |
| Mar 31, 2015 | 29,561.00 |
| Dec 31, 2014 | 15,608.00 |
| Sep 30, 2014 | 26,309.00 |
| Jun 30, 2014 | 22,825.00 |
| Mar 31, 2014 | 42,884.00 |
| Dec 31, 2013 | 64,434.00 |
| Sep 30, 2013 | 58,878.00 |
| Jun 30, 2013 | 49,613.00 |
| Mar 31, 2013 | 55,430.00 |
| Dec 31, 2012 | 69,795.00 |
| Sep 30, 2012 | 72,379.00 |
| Jun 30, 2012 | 39,422.00 |
| Mar 31, 2012 | 63,314.00 |
| Dec 31, 2011 | 92,644.00 |
| Sep 30, 2011 | 44,330.00 |
| Jun 30, 2011 | 55,085.00 |